Addus HomeCare Corporation

Valuation Analysis

About the Company

Addus HomeCare Corporation en bref

Addus HomeCare Corporation (ADUS) is currently trading at 82,15 € with a market capitalization of 1,5 Md €. The trailing P/E ratio stands at 17.39x, with a forward P/E of 12.61x. The 52-week range spans from 76,67 € to 108,48 €; the current price is 24.3% below the yearly high. Year-over-year revenue growth stands at +7.7%. The net profit margin stands at 6.89%.

💰 Dividende

Addus HomeCare Corporation currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

13 analystes évaluent Addus HomeCare Corporation (ADUS) au consensus : None. L'objectif de cours moyen est de 115,67 €, soit un potentiel de +40.82% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 80,20 € à 135,12 €.

Addus HomeCare Corporation : la thèse d'investissement en détail

Addus HomeCare Corporation (ADUS) operates in the Healthcare — specifically Medical Care Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Valorisation en contexte

With a PEG ratio of 0.91, the price-to-earnings multiple is actually below the company's growth rate — classic value-meets-growth territory that Peter Lynch would have called a 'GARP' opportunity.

À surveiller

• The forward P/E of 12.61x is meaningfully below the trailing 17.39x — analysts expect earnings to step up; the next earnings release is the test.
• The price sits in the lower quartile of the 52-week range — value hunters often start scaling in around this zone if fundamentals hold.
• The analyst consensus price target implies 40.82% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Thèse d'investissement : forces et faiblesses

Aperçu technique

The price is in a transition zone relative to the moving averages — no clear signal.

Profil de risque

The data points to relatively defensive market behavior, elevated short interest (6.21%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Addus HomeCare Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.